ADHD

Patients with chronic pain are prime candidates for a medication review because of possible interactions, toxicities, and adherence issues.

An analysis of the top 200 drugs by prescriptions dispensed and total sales reveals key trends in today's pharmaceutical market.

The wider range of symptoms found in Asperger's syndrome makes the disorder a challenge to diagnose and treat.

As manufacturers and government agencies squabble over quotas, patients scramble to get their preferred treatment regimens.

Updated recommendations from the AAP provide guidance on treatment of ADHD in different age groups, and emphasize the importance of behavioral therapy.

The FDA approved Kapvay (clonidine hydrochloride extended -release) as a monotherapy and adjunctive therapy for the treatment of attention- deficit/hyperactivity disorder in children and adolescents aged 6 to 17 years.